Malaria remains a significant global healthcare challenge Despite much progress that has been made to battle the disease, it remains a significant global healthcare challenge. It is found in more than 100 countries mainly in tropical regions of the world, disproportionately affecting poor and vulnerable populations. The ethos at Sanger demands that infectious diseases, such as malaria, currently afflicting the developing world receive equal attention and resource to the diseases of affluence such as cancer and type 2 diabetes.
To effectively tackle malaria, we need better vaccines, medicines and disease surveillance. At Sanger, we are working to address all three of these areas.
These case studies describe ambitious projects, backed by Sanger’s Technology Transfer Team, and focused on eliminating malaria globally.
Read this case study now 
